Dr. Nathan Edward Nachlas, MD

Dr. Nachlas practices at ENT and Allergy Associates of Florida in Boca Raton, Florida.

Dr. Nachlas' NPI, 1497737647, was assigned on November 15, 2005. Dr. Nachlas graduated from Pritzker School of Medicine in 1980. Dr. Nachlas holds Florida license ME 49831.

Dr. Nachlas' primary practice is ENT and Allergy Associates of Florida, at 900 NW 13th St, Boca Raton, FL 33486 in Palm Beach County. The practice phone is (561) 338-3267.

Dr. Nachlas' primary practice is ENT and Allergy Associates of Florida in Boca Raton, Florida. The medical group on file is ENT & Allergy Associates of Florida. Dmand AI also links Dr. Nachlas to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nachlas practices. Vendor and product names are available with a free account.

Facial plastic surgery is Dr. Nachlas' primary specialty in the NPI Registry, under taxonomy code 207YS0123X. Dr. Nachlas is board certified in facial plastic and reconstructive surgery by the American Board of Facial Plastic and Reconstructive Surgery. Dmand AI has Dr. Nachlas' licenses on file in 3 states: Florida, California and Maryland.

Dmand AI lists chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, endoscopic sinus surgery, upper respiratory infection (URI) and vertigo among the conditions Dr. Nachlas treats.

CMS data shows 2,690 Medicare services from Dr. Nachlas across 17 procedure codes in 2024, for 295 Medicare patients. Medicare paid $188,875 for them. Every service was in an office.

CMS counts 295 Medicare patients who saw Dr. Nachlas in 2024. The largest group is 75 to 84, with 131 patients. 75% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Nachlas' median patient age at 65, with 48% women.

In 2024, Dr. Nachlas wrote 503 Medicare Part D claims for 173 patients. 98% of them were for generic drugs. CMS names the drug for 457 of them, across 8 drugs with 11 or more claims each, at $9,216 in total drug cost. In 2023, CMS named 337 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Nachlas for performance year 2024, reported individually.

Dmand AI links 13 papers to Dr. Nachlas, published from 2017 to 2025. 2019 was the busiest year, with 2. The most frequent topics are Nose, Dilatation and Rhinitis. Dr. Nachlas has published most often in Laryngoscope. Dr. Nachlas' most frequent co-authors are Randall A. Ow, Gregory M. Abbas, MD and Moises Alberto Arriaga, MD.

Dmand AI links Dr. Nachlas to 3 clinical trials. Conditions studied include Nasal Obstruction and Airway Obstruction. Spirox, Inc. sponsors the most, 2. Open Payments lists research payments to Dr. Nachlas that name 2 trials.

CMS Open Payments shows 198 general payments to Dr. Nachlas from 31 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 88% of the total. Arrinex, Inc. paid the most, $47,805. It also lists 22 research payments totaling $114,060 from 2017 to 2018, naming 2 clinical trials.

Dmand AI lists 3 awards for Dr. Nachlas, most recently Top Doctors: Florida in 2000.

Dr. Nachlas graduated from Pritzker School of Medicine in 1980. Dr. Nachlas is a member of NHS.

Dr. Nachlas is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.